Some here, myself included, invested a few years ago under different financial circumstances. I wish I could invest my original amount down here (although I probably wouldn't).
Sure all biotechs need dilutive funding. But the amount of dilution over a relatively short time with CHM is extreme. Terrible management.
Early investors need unicorn returns from here just to break even. If the company gets bought for a few billion dollars a couple of years from now, many early investors will still have negative returns. That's the power of relentless and massive dilution.
CHM Price at posting:
0.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)